Duarte Ira
SEC CIK 1488864 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | EVP, CFO | 285.2K | $75.7K | — | 24 | 2023-11-16 | 2026-07-30 |
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-03 09:50 | 2026-07-30+ | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +25.2K | 285.2K | +10% | — |
| DM | 2026-08-03 09:50 | 2026-07-30+ | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | F - Tax | $0.5 | -7,176 | 281.9K | -2% | -$3,588 |
| D | 2026-07-20 15:54 | 2026-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +3,874 | 264.9K | +1% | — |
| D | 2026-07-20 15:54 | 2026-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | F - Tax | $0.47 | -1,101 | 263.8K | -0.4% | -$517.47 |
| D | 2026-06-17 10:52 | 2026-06-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +12.5K | 264.6K | +5% | — |
| D | 2026-06-17 10:52 | 2026-06-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | F - Tax | $0.38 | -3,555 | 261.1K | -1% | -$1,351 |
| DM | 2026-05-04 11:56 | 2026-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +25.2K | 252.1K | +11% | — |
| D | 2026-04-21 09:13 | 2026-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +3,874 | 215.9K | +2% | — |
| D | 2026-02-03 | 2026-01-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +11.7K | 195.4K | +6% | — |
| D | 2026-01-20 | 2026-01-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +3,875 | 183.7K | +2% | — |
| D | 2025-11-04 | 2025-10-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +11.7K | 179.8K | +7% | — |
| D | 2025-10-21 | 2025-10-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +3,874 | 168.1K | +2% | — |
| D | 2025-08-04 | 2025-07-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +11.7K | 164.2K | +8% | — |
| D | 2025-07-22 | 2025-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +3,874 | 152.5K | +3% | — |
| D | 2025-06-17 | 2025-06-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +12.5K | 148.6K | +9% | — |
| D | 2025-05-02 | 2025-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +11.7K | 136.1K | +9% | — |
| D | 2025-04-22 | 2025-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +3,875 | 124.5K | +3% | — |
| D | 2025-01-22 | 2025-01-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +3,874 | 120.6K | +3% | — |
| D | 2024-10-21 | 2024-10-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +3,874 | 108.0K | +4% | — |
| D | 2024-07-22 | 2024-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +3,875 | 104.1K | +4% | — |
| D | 2024-06-17 | 2024-06-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +12.5K | 100.3K | +14% | — |
| D | 2024-04-19 | 2024-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | M - OptEx | — | +3,874 | 88.9K | +5% | — |
| D | 2024-04-19 | 2024-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | F - Tax | $2.64 | -1,122 | 87.8K | -1% | -$2,962 |
| 2023-11-17 | 2023-11-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Duarte Ira | EVP, CFO | P - Purchase | $0.89 | +85.0K | 85.0K | New | +$75.7K |
Purchase Sale Sale after option exercise All abbreviations